Antibody-drug conjugates targeting CDCP1 and uses thereof
TW202635725APending Publication Date: 2026-09-01CSPC MEGALITH BIOPHARMACEUTICAL CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114141205
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-10-25
- Filing Date
- 2025-10-23
- Publication Date
- 2026-09-01
Smart Images
Figure TWG2TA001074481_001 
Figure TWG2TA001074481_002 
Figure TWG2TA001074481_003
Abstract
A-(Con-L-D)m (I)Provided are anti-CDCP1 antibody-drug conjugates as represented by formula (I), along with uses and methods of preparation thereof. The CDCP1-targeting antibody-drug conjugates enable the treatment of various malignant tumors and hold potential clinical application value, particularly for certain malignancies that currently lack effective treatment solutions. A-(Con-L-D)m (I)
Need to check novelty before this filing date? Find Prior Art